MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字H20249141

October 22, 2024

Drug Information

盐酸莫西沙星滴眼液

眼用制剂

0.5%(0.4ml:2mg,按C₂₁H₂₄FN₃O₄计)

化学药品

October 22, 2024

Company Information

Applicant Company

河南省项城市平安大道东段216号

Manufacturing Company

河南省项城市产业集聚区东方大道路北136号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath